Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis - PubMed (original) (raw)
Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis
Marina Berenguer et al. Liver Transpl. 2003 Mar.
Free article
Abstract
An increase in the number of hepatitis C virus (HCV)-infected transplant recipients at need for repeated liver transplantation is anticipated. To date, there is a certain reluctance to accept these patients because of an increased organ shortage, early reports suggesting a poor outcome, and uncertainty regarding the natural history of recurrent hepatitis C in the second graft. The aim of this study is to determine the outcome of patients undergoing retransplantation for HCV-related graft cirrhosis. Of 49 transplant recipients with HCV-related allograft cirrhosis, 31 patients developed decompensation with criteria for retransplantation. Thirteen patients were denied this option. Of the 18 patients accepted, 6 patients died while on the waiting list (5 patients died of graft cirrhosis at a median of 3.2 months of listing), and 12 patients have undergone retransplantation (median, 10 months since HCV cirrhosis). After retransplantation, 8 patients (67%) died at a median of 8 months, and 4 patients (33%) remain alive after 1.9 years of follow-up. Causes and times of death from retransplantation were: surgical complications, n = 3 (perioperative period); HCV cirrhosis of the second graft, n = 2 (at 9 and 54 months); fibrosing cholestatic hepatitis, n = 1 (at 2 years); lymphoproliferative disorder, n = 1 (at 7 months); and endocarditis, n = 1 (at 3.5 years, with underlying cirrhosis). Of the 4 patients alive, fibrosis stages in the last biopsy specimens are stage 1 (n = 1), stage 3 (n = 1), and stage 4 or cirrhosis (n = 1; one patient has not undergone biopsy), despite antiviral therapy. The outcome of retransplantation for HCV cirrhosis of the first graft is very poor because of multiple complications. The severity of recurrent HCV disease in the second graft seems to be related to that observed in the first graft.
Similar articles
- High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
Prieto M, Berenguer M, Rayón JM, Córdoba J, Argüello L, Carrasco D, García-Herola A, Olaso V, De Juan M, Gobernado M, Mir J, Berenguer J. Prieto M, et al. Hepatology. 1999 Jan;29(1):250-6. doi: 10.1002/hep.510290122. Hepatology. 1999. PMID: 9862874 Clinical Trial. - Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989.
Loinaz C, Lumbreras C, Moreno E, Colina F, Fuertes A, Gómez R, Jiménez C, González-Pinto I, García I, Rojas J, Bellorín C. Loinaz C, et al. Hepatogastroenterology. 2001 Sep-Oct;48(41):1435-42. Hepatogastroenterology. 2001. PMID: 11677981 - Long-term outcome of hepatitis C infection after liver transplantation.
Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, Maertens G, Williams R. Gane EJ, et al. N Engl J Med. 1996 Mar 28;334(13):815-20. doi: 10.1056/NEJM199603283341302. N Engl J Med. 1996. PMID: 8596547 - The natural history of recurrent hepatitis C and what influences this.
Gane EJ. Gane EJ. Liver Transpl. 2008 Oct;14 Suppl 2:S36-44. doi: 10.1002/lt.21646. Liver Transpl. 2008. PMID: 18825724 Review. - Retransplantation for recurrent hepatitis C: positive aspects.
McCashland TM. McCashland TM. Liver Transpl. 2003 Nov;9(11):S67-72. doi: 10.1053/jlts.2003.50249. Liver Transpl. 2003. PMID: 14586899 Review.
Cited by
- Hepatitis B and C.
Karnsakul W, Schwarz KB. Karnsakul W, et al. Pediatr Clin North Am. 2017 Jun;64(3):641-658. doi: 10.1016/j.pcl.2017.01.007. Pediatr Clin North Am. 2017. PMID: 28502443 Free PMC article. Review. - Retransplantation for graft failure in chronic hepatitis C infection: a good use of a scarce resource?
Rowe IA, Barber KM, Birch R, Curnow E, Neuberger JM. Rowe IA, et al. World J Gastroenterol. 2010 Oct 28;16(40):5070-6. doi: 10.3748/wjg.v16.i40.5070. World J Gastroenterol. 2010. PMID: 20976844 Free PMC article. - Clinical features of hepatitis C virus carriers with persistently normal alanine aminotransferase levels.
Uto H, Mawatari S, Kumagai K, Ido A, Tsubouchi H. Uto H, et al. Hepat Mon. 2012 Feb;12(2):77-84. doi: 10.5812/hepatmon.829. Epub 2012 Feb 29. Hepat Mon. 2012. PMID: 22509183 Free PMC article. - Host cell mTORC1 is required for HCV RNA replication.
Stöhr S, Costa R, Sandmann L, Westhaus S, Pfaender S, Anggakusuma, Dazert E, Meuleman P, Vondran FW, Manns MP, Steinmann E, von Hahn T, Ciesek S. Stöhr S, et al. Gut. 2016 Dec;65(12):2017-2028. doi: 10.1136/gutjnl-2014-308971. Epub 2015 Aug 14. Gut. 2016. PMID: 26276683 Free PMC article. - Liver fibrosis.
Bataller R, Brenner DA. Bataller R, et al. J Clin Invest. 2005 Feb;115(2):209-18. doi: 10.1172/JCI24282. J Clin Invest. 2005. PMID: 15690074 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical